Bolt Biotherapeutics Stock Price History

BOLT Stock  USD 0.49  0.01  2.00%   
If you're considering investing in Bolt Stock, it is important to understand the factors that can impact its price. As of today, the current price of Bolt Biotherapeutics stands at 0.49, as last reported on the 1st of February, with the highest price reaching 0.51 and the lowest price hitting 0.49 during the day. Bolt Biotherapeutics secures Sharpe Ratio (or Efficiency) of -0.14, which signifies that the company had a -0.14 % return per unit of risk over the last 3 months. Bolt Biotherapeutics exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Bolt Biotherapeutics' Standard Deviation of 3.22, risk adjusted performance of (0.11), and Mean Deviation of 2.3 to double-check the risk estimate we provide.
  
At this time, Bolt Biotherapeutics' Other Stockholder Equity is comparatively stable compared to the past year. Capital Stock is likely to gain to 1,208 in 2025, whereas Liabilities And Stockholders Equity is likely to drop slightly above 147.8 M in 2025. . At this time, Bolt Biotherapeutics' Price Book Value Ratio is comparatively stable compared to the past year. Price To Book Ratio is likely to gain to 0.35 in 2025, whereas Price Earnings To Growth Ratio is likely to drop 0.03 in 2025. Bolt Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1424

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsBOLT

Estimated Market Risk

 3.23
  actual daily
28
72% of assets are more volatile

Expected Return

 -0.46
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.14
  actual daily
0
Most of other assets perform better
Based on monthly moving average Bolt Biotherapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bolt Biotherapeutics by adding Bolt Biotherapeutics to a well-diversified portfolio.
Price Book
0.2672
Enterprise Value Ebitda
0.9324
Price Sales
1.6795
Shares Float
25 M
Wall Street Target Price
1.75

Bolt Biotherapeutics Stock Price History Chart

There are several ways to analyze Bolt Stock price data. The simplest method is using a basic Bolt candlestick price chart, which shows Bolt Biotherapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest PriceNovember 4, 20240.67
Lowest PriceJanuary 31, 20250.49

Bolt Biotherapeutics February 1, 2025 Stock Price Synopsis

Various analyses of Bolt Biotherapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Bolt Stock. It can be used to describe the percentage change in the price of Bolt Biotherapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Bolt Stock.
Bolt Biotherapeutics Price Action Indicator(0.02)
Bolt Biotherapeutics Price Daily Balance Of Power(0.50)
Bolt Biotherapeutics Price Rate Of Daily Change 0.98 

Bolt Biotherapeutics February 1, 2025 Stock Price Analysis

When benchmark price declines in a down market, there may be an uptick in Bolt Stock price where buyers come in believing the asset is cheap or selling overdone. The opposite is true when the market is bullish. You can use Bolt Biotherapeutics intraday prices and daily technical indicators to check the level of noise trading in Bolt Stock and then apply it to test your longer-term investment strategies against Bolt.

Bolt Stock Price History Data

The price series of Bolt Biotherapeutics for the period between Sun, Nov 3, 2024 and Sat, Feb 1, 2025 has a statistical range of 0.19 with a coefficient of variation of 9.91. The prices are distributed with arithmetic mean of 0.57. The median price for the last 90 days is 0.57. The company had 3:2 stock split on January 31, 2008. Bolt Biotherapeutics issued dividends on Aug 29, 2014.
OpenHighLowCloseVolume
02/01/2025
 0.50  0.51  0.49  0.49 
01/31/2025 0.50  0.51  0.49  0.49  46,139 
01/30/2025 0.50  0.52  0.49  0.50  205,705 
01/29/2025 0.50  0.51  0.50  0.50  56,450 
01/28/2025 0.52  0.52  0.49  0.50  87,268 
01/27/2025 0.52  0.53  0.50  0.51  140,808 
01/24/2025 0.52  0.55  0.50  0.51  206,705 
01/23/2025 0.55  0.56  0.51  0.52  264,814 
01/22/2025 0.54  0.55  0.52  0.53  101,110 
01/21/2025 0.52  0.59  0.51  0.53  130,563 
01/17/2025 0.52  0.52  0.51  0.51  57,951 
01/16/2025 0.55  0.55  0.50  0.52  80,159 
01/15/2025 0.51  0.53  0.50  0.52  333,823 
01/14/2025 0.53  0.53  0.51  0.52  147,769 
01/13/2025 0.54  0.54  0.51  0.53  125,897 
01/10/2025 0.57  0.57  0.54  0.54  126,298 
01/08/2025 0.61  0.62  0.55  0.57  168,191 
01/07/2025 0.62  0.63  0.58  0.58  71,228 
01/06/2025 0.61  0.62  0.57  0.62  177,797 
01/03/2025 0.57  0.60  0.56  0.59  263,217 
01/02/2025 0.56  0.59  0.54  0.57  226,512 
12/31/2024 0.59  0.59  0.54  0.54  191,232 
12/30/2024 0.52  0.59  0.52  0.57  439,767 
12/27/2024 0.51  0.53  0.50  0.52  257,136 
12/26/2024 0.49  0.52  0.49  0.51  222,866 
12/24/2024 0.51  0.52  0.50  0.51  71,780 
12/23/2024 0.50  0.52  0.48  0.51  266,564 
12/20/2024 0.49  0.52  0.49  0.50  69,985 
12/19/2024 0.50  0.53  0.49  0.50  287,092 
12/18/2024 0.52  0.54  0.50  0.50  137,667 
12/17/2024 0.53  0.54  0.52  0.54  68,809 
12/16/2024 0.53  0.53  0.50  0.52  529,178 
12/13/2024 0.54  0.55  0.51  0.53  107,380 
12/12/2024 0.56  0.59  0.52  0.53  318,121 
12/11/2024 0.56  0.57  0.55  0.56  175,574 
12/10/2024 0.57  0.58  0.56  0.57  127,960 
12/09/2024 0.58  0.61  0.57  0.57  290,027 
12/06/2024 0.59  0.60  0.58  0.58  90,246 
12/05/2024 0.58  0.60  0.55  0.56  263,216 
12/04/2024 0.63  0.63  0.57  0.58  258,843 
12/03/2024 0.63  0.65  0.63  0.63  41,837 
12/02/2024 0.63  0.65  0.62  0.63  65,673 
11/29/2024 0.63  0.65  0.62  0.64  132,236 
11/27/2024 0.63  0.64  0.60  0.63  127,757 
11/26/2024 0.58  0.65  0.57  0.63  241,934 
11/25/2024 0.58  0.61  0.56  0.60  189,134 
11/22/2024 0.56  0.58  0.56  0.58  158,291 
11/21/2024 0.57  0.59  0.55  0.57  80,916 
11/20/2024 0.56  0.59  0.55  0.57  58,935 
11/19/2024 0.56  0.59  0.54  0.56  132,768 
11/18/2024 0.56  0.58  0.55  0.56  212,384 
11/15/2024 0.62  0.62  0.56  0.57  377,476 
11/14/2024 0.62  0.63  0.61  0.62  30,949 
11/13/2024 0.63  0.65  0.61  0.62  105,737 
11/12/2024 0.64  0.66  0.64  0.64  72,958 
11/11/2024 0.66  0.66  0.63  0.64  25,502 
11/08/2024 0.65  0.67  0.63  0.65  116,386 
11/07/2024 0.64  0.67  0.64  0.65  65,657 
11/06/2024 0.64  0.69  0.63  0.65  140,637 
11/05/2024 0.66  0.67  0.66  0.66  41,105 
11/04/2024 0.66  0.67  0.66  0.67  32,789 

About Bolt Biotherapeutics Stock history

Bolt Biotherapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Bolt is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Bolt Biotherapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Bolt Biotherapeutics stock prices may prove useful in developing a viable investing in Bolt Biotherapeutics
Last ReportedProjected for Next Year
Common Stock Shares Outstanding43.5 M35.4 M
Net Loss-79.3 M-83.3 M

Bolt Biotherapeutics Quarterly Net Working Capital

39.06 Million

Bolt Biotherapeutics Stock Technical Analysis

Bolt Biotherapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Bolt Biotherapeutics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Bolt Biotherapeutics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Did you try this?

Run Odds Of Bankruptcy Now

   

Odds Of Bankruptcy

Get analysis of equity chance of financial distress in the next 2 years
All  Next Launch Module

Bolt Biotherapeutics Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Bolt Biotherapeutics' price direction in advance. Along with the technical and fundamental analysis of Bolt Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Bolt to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Tools for Bolt Stock Analysis

When running Bolt Biotherapeutics' price analysis, check to measure Bolt Biotherapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bolt Biotherapeutics is operating at the current time. Most of Bolt Biotherapeutics' value examination focuses on studying past and present price action to predict the probability of Bolt Biotherapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bolt Biotherapeutics' price. Additionally, you may evaluate how the addition of Bolt Biotherapeutics to your portfolios can decrease your overall portfolio volatility.